Health and Human Services Secretary Kathleen Sebelius met at the White House with the CEOs of Indianapolis-based WellPoint,
Aetna, Cigna, UnitedHealth Group, as well as several state insurance commissioners.
The investment will greatly expand the company’s research and development capacity and is a major win for the Indiana
life sciences industry. Dow AgroSciences expects most of the positions to pay between $65,000 and $95,000 annually.
Dr. Gregory N. Larkin, the former global medical director at Eli Lilly and Co., will replace Dr. Judy Monroe, who is leaving
to become deputy director of the Centers for Disease Control and Prevention.
The former Guidant Corp. CEO and long-time Eli Lilly exec said he and his family will be returning to Indianapolis.
Local Dow Chemical subsidiary expects to launch five new biotech products by 2012.
Drug developer Transition Therapeutics Inc. said Wednesday that it will pay $1 million to license a group of potential diabetes
drugs from Eli Lilly and Co.
Dr. Patrick J. Loehrer Sr. replaces Dr. Stephen D. Williams, the center’s founding director, who died of cancer in February
2009.
A consumer watchdog group filed a lawsuit Monday against WellPoint’s California subsidiary on behalf of policyholders, claiming
they were pushed to take coverage with fewer benefits and higher deductibles.
Dr. Judy Monroe, after five years as Indiana’s public health leader, will spearhead communication between federal and state
health agencies.
Carmel-based insurer swings to a profit, but earnings from operations decline.
The California attorney general has demanded documents from several health insurers, including Indianapolis' WellPoint,
believing that their rate-setting and claims practices might be illegal.
While insurers get the blame for rising health-care costs for consumers, surging fees from hospitals and the growing dominance
of such providers may be just as responsible for driving up expenses, according to a new study examining California's
market.
Carmel-based insurer Conseco Inc. has been profitable for four straight quarters.
The House has approved legislation that would ban smoking in public places statewide except casinos and pari-mutuel horse
racing venues.
Amid attacks from Democrats over high executive salaries, Angela Braly testified in Washington, D.C., on Wednesday that big
insurance-premium increases are
the result of growing price tags for hospital care and pharmaceuticals.
CEO Angela Braly is defending individual premium hikes one day before Obama's summit to debate his new reform proposal
with Republicans.
The pharmacy benefits manager, which has major operations in Whitestown, said fourth quarter profit rose 24 percent.
Executives are scheduled to testify Tuesday before a California legislative committee and on Wednesday before a U.S. House
of Representatives committee about big premium increases.
Three major U.S. drugmakers said they have formed a not-for-profit company in Asia to focus on cancer research and treatments.
California’s insurance regulator said Monday his office has found more than 700 violations by the state’s largest for-profit
health insurer, a subsidiary of Indianapolis-based WellPoint.
